100 first days in ChemoTech's new Indian organization
It has now been 100 days since ChemoTech's new Indian Manager Ashim Puhorit set the foundation of ChemoTech's new organization in India.
It has been a hectic period and now it’s beginning to yield results, says Ashim, Manager and Chairman of the Board of Scandinavian Meditech, ChemoTech's subsidiary in India.
During these days, we have been actively visiting hospitals and clinics in a total of five states. It has been intense and rewarding. At the same time, it is extremely sad to meet all the cancerous people who are at the cancer clinics to get the doctors' help and attention.
At the beginning of 2018, we secured the relationships with our Key Opinion Leaders, which now play an active role in our sales and training of new doctors.
We have active discussions with over a handful of new agents, each of which has a long and successful experience of selling medical technology to the leading hospitals and clinics in their regions. These agents, unlike traditional agents, work only against a number of predetermined customers.
It is amazing that we have received requests from two different hospitals, whereof one with long experience of first-generation electrochemotherapy, who are now interested in getting training and starting treatment with next-generation electrochemotherapy, such as IQWave ™.
For more information, please contact:
Mohan Frick, CEO
+46 (0)10-218 93 03
Scandinavian ChemoTech AB (publ)
ChemoTech is a young and dynamic life science company that possesses a great medical expertise and technical knowledge. Our latest launch of IQWave™ is an innovation within electrochemotherapy, that is adapted for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered in Malmö, in the midst of the medical technology expansionary Öresund region.